Target intelligence / Profile preview

Transmembrane phosphoinositide 3-phosphatase and tensin homolog 2 (TPTE2)

Target
TPTE2
Molecular classification
Enzyme, Protein tyrosine phosphatase (class I, Cys-based), Dual specific phosphatase (DSP), PTEN-like protein, Integral membrane protein
01

Overview

Transmembrane phosphoinositide 3-phosphatase and tensin homolog 2 (TPTE2) is an integral membrane enzyme related to the tumor suppressor PTEN, encoded by the TPTE2 gene (also known as TPIP). It acts as a lipid phosphatase, specifically removing the phosphate in the D3 position from phosphatidylinositol 3,4,5-trisphosphate (PIP3), thereby generating phosphatidylinositol 4,5-bisphosphate and inorganic phosphate[1][2][5]. TPTE2 is classified within the class I cysteine-based protein tyrosine phosphatases, and more specifically in the PTEN-like subgroup. Its enzymatic activity is important in regulating phosphoinositide signaling pathways, particularly those involved in cell growth, proliferation, and survival. TPTE2 is primarily localized to membranes such as the endoplasmic reticulum and Golgi, and is expressed across various tissues, with potential enrichment in reproductive organs based on the broader TPTE family[4][3]. Dysregulation of phosphoinositide metabolism, the pathway in which TPTE2 participates, is implicated in certain cancer syndromes (such as Cowden syndrome 1), but TPTE2 itself is not currently a therapeutic target of any approved drugs[1][2][5].

Other names
Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase TPTE2TPIPLipid phosphatase TPIPTPTE and PTEN homologous inositol lipid phosphatasePTEN-like inositol lipid phosphataseTPIP lipid phosphataseTransmembrane phosphoinositide 3-phosphatase and tensin 2-like protein
02

Biological functions

Lipid phosphatase activity (removes 3-phosphate from phosphatidylinositol 3,4,5-trisphosphate)Signal transductionPhosphoinositide metabolismMay participate in spermatogenic or endocrine cell signaling (based on TPTE family function)
03

Disease associations

Cancer (notably Cowden syndrome 1)Other: Potential involvement in disease where aberrant PI3K signaling is implicated

Beyond the preview

Go deeper on Transmembrane phosphoinositide 3-phosphatase and tensin homolog 2 (TPTE2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Transmembrane phosphoinositide 3-phosphatase and tensin homolog 2 (TPTE2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call